Recent News for EQ - Equillium, Inc.

Date Title
Aug 12 Equillium EPS beats by $0.06
Aug 12 Equillium Reports Second Quarter 2019 Financial Results and Recent Highlights
Aug 7 The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Jul 26 Stocks That Managed to Breach 52-Week Lows Friday
Jul 10 Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma
Jul 2 Amarin and Celyad among healthcare gainers; CEL-SCI and Oramed Pharmaceuticals among losers
Jul 2 Benzinga's Top Upgrades, Downgrades For July 2, 2019
May 23 Equillium to Present at Jefferies 2019 Healthcare Conference
May 13 Equillium misses by $0.04
May 13 Equillium Reports First Quarter 2019 Financial Results and Recent Highlights
May 9 95 Biggest Movers From Yesterday
May 6 Equillium Expands Scientific and Clinical Advisory Team
Apr 18 The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio
Apr 16 Equillium to Present at Solebury Trout Class of 2018 Biotech IPO Investor Day
Mar 28 Equillium to Present at H.C. Wainwright Global Life Sciences Conference
Mar 27 Equillium reports Q4 results
Mar 27 Equillium Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Highlights
Mar 1 Equillium (EQ) Investor Presentation - Slideshow
Feb 26 Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis
Feb 22 Key events next week - healthcare
Feb 21 Equillium to Present at Leerink Partners Global Healthcare Conference
Feb 19 Equillium to Host Business Update Call on February 26
Back to the Main EQ Page...